A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy

AIMS: Metformin is the first line drug for patients diagnosed with type-2 diabetes; however, the impact of different treatment escalation strategies after metformin failure has thus far not been investigated in a real world situation. The registry described herein goes some way to clarifying treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Gitt, Anselm K, Bramlage, Peter, Schneider, Steffen, Tschöpe, Diethelm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324641/
https://www.ncbi.nlm.nih.gov/pubmed/25645672
http://dx.doi.org/10.1186/s12933-015-0172-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324641/
https://www.ncbi.nlm.nih.gov/pubmed/25645672
http://dx.doi.org/10.1186/s12933-015-0172-9

Ejemplares similares